awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26852509-6E0ACAB0-522D-402E-85BF-18E1B135B343
Q26852509-6E0ACAB0-522D-402E-85BF-18E1B135B343
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26852509-6E0ACAB0-522D-402E-85BF-18E1B135B343
Lessons learned from the bevacizumab experience
P2860
Q26852509-6E0ACAB0-522D-402E-85BF-18E1B135B343
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26852509-6E0ACAB0-522D-402E-85BF-18E1B135B343
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2ff5f3d429fffa6dae4fa5d38ce3ca972b17c5c3
P2860
Incorporation of bevacizumab in the primary treatment of ovarian cancer.